MedPath

TARO-SIMVASTATIN

TARO-SIMVASTATIN

Approved
DIN Number

02329174

Drug Class

Human

Market Date

Jul 20, 2009

Company
HC

sun pharma canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02329174
AIG Number0122415002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C10AA01 SIMVASTATIN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:06.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

SIMVASTATINActive
Strength: 40 MG
Monograph: SIMVASTATIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.